Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency-Reference-Cited by-同舟云学术

Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

Published:2008-01-01 Issue:1 Volume:47 Page:27-35
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Lichtenstein Kenneth A,Armon Carl,Buchacz Kate,Chmiel Joan S,Moorman Anne C,Wood Kathleen C,Holmberg Scott D,Brooks John T

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference40 articles.

1. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators [see comment].;Palella;N Engl J Med,1998

2. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies [erratum appears in Lancet 2002;360:1178].;Egger;Lancet,2002

3. Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements.;Fahey;AIDS,1998

4. CD4 cell count and HIV DNA level are independent predictors of disease progression after primary HIV Type 1 infection in untreated patients.;Gougard;Clin Infect Dis,2006

5. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load.;Deeks;Blood,2004

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of routine non-gated CT chest in detection of subclinical atherosclerotic calcifications of coronary arteries in hospitalised HIV patients;The British Journal of Radiology;2020-05-01

2. New antiretroviral agent use affects prevalence of HIV drug resistance in clinical care populations;AIDS;2018-11-13

3. Adverse Drug Reactions Among Patients Initiating Second-Line Antiretroviral Therapy in South Africa;Drug Safety;2018-07-24

4. Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study;Atherosclerosis;2018-07

5. Changes in Cardiovascular Disease Risk Factors With Immediate Versus Deferred Antiretroviral Therapy Initiation Among HIV‐Positive Participants in the START (Strategic Timing of Antiretroviral Treatment) Trial;Journal of the American Heart Association;2017-05-05